Rocket, Lab

Rocket Lab Locks In 47 Synspective Missions and a Fully Funded Iridium Takeover

Published on 10/03/2026 at 05:30 | Editorial boerse-global.de

Rocket Lab shares gained 4.6% after Citi began coverage with a Buy rating and Synspective booked 20 more Electron launches, pushing its manifest past 100 missions.

Rocket Lab Stock Rises 4.6% as Citi Starts Coverage With $105 Target
Rocket Lab Locks In 47 Synspective Missions and a Fully Funded Iridium Takeover Illustration mit AI erstellt.

Rocket Lab's equity finished Friday's session at €65.70, up 4.6%, as a sector-wide rebound in space names gave the stock a lift and investors continued to digest a run of operational and strategic wins. The advance extends a 30-day gain that now stands at 21%, a swing that suggests the market is warming to the company's transformation story after months of skepticism.

The most tangible evidence of that transformation sits in the order book. Synspective, the Japanese radar-satellite specialist, has signed on for 20 additional Electron launches to be flown between 2028 and 2031 — the largest commercial launch contract the vehicle has won to date. The deal lifts the customer's total reservation to 47 missions, 13 of which Rocket Lab has already delivered since 2020, most recently in late September.

That single contract pushed Rocket Lab's overall manifest past the 100-mission mark for the first time. For a capital-hungry industry, a three-digit backlog represents a degree of planning certainty that is genuinely rare, and it reflects a broader shift in how satellite operators buy: not one-off rides, but dedicated corridors booked years ahead.

Citi Opens Coverage With a $105 Target

Sentiment got a further nudge on Thursday when Citi analyst John Godyn initiated coverage with a Buy rating and a $105 price target, citing room for the shares to recover. The call landed alongside the Synspective news, reinforcing the view that Rocket Lab is steadily cementing its position as the leading private launch provider outside SpaceX.

The company also demonstrated in late September that its cadence holds up in practice, completing its 97th Electron mission and delivering a Synspective satellite to orbit. Reliable turnaround matters as much as contract signatures in this business, since constellation builders can ill afford delays in rideshare schedules. Dedicated small rockets like Electron offer customers the precise altitude and orbital plane that global radar networks require.

Should investors sell immediately? Or is it worth buying Rocket Lab?

Iridium Shareholders Clear the Way

The bigger strategic lever, however, is Rocket Lab's push to become a fully integrated space company. Roughly a week ago, Iridium Communications shareholders approved the takeover offer by an overwhelming margin — about 99.6% of votes cast, representing roughly 81.0% of eligible shares — clearing the path for the combination.

The financing is already in place. A capital raise brought in gross proceeds of about $1.944 billion, which retires a $3.6 billion bridge facility and leaves the purchase fully funded. Closing is targeted for mid-2027, subject to outstanding regulatory approvals.

Integration risk is real, but the logic is compelling: Rocket Lab gains direct access to global communications networks and a predictable cash flow stream. Rather than merely ferrying third-party satellites skyward, the company captures value in orbit itself.

The Next Test Comes at the Launch Pad

A full manifest does not guarantee profitable cash flow, and the market has no shortage of questions. Contract values and margins on the new Synspective batch were not disclosed, so attention turns to manufacturing unit costs and actual launch tempo at Launch Complex 1.

Capital demands are also mounting. Beyond Electron, management is developing the medium-lift Neutron rocket, with a first flight targeted for the fourth quarter, while simultaneously steering the Iridium acquisition toward its mid-2027 completion.

Growth-oriented space names tend to be unforgiving when engine tests slip or launch windows move, and delays in approvals or operational setbacks can dent the shares at any time. Even so, the strategic direction is coherent, the takeover is paid for, and the launch business is delivering on schedule. If management holds this course, Friday's rally may prove to be the opening chapter of a durable re-rating rather than a fleeting bounce.

Ad

Rocket Lab Stock: New Analysis - 3 October

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

Disclaimer...

en | US7731211089 | ROCKET | boerse | 70219306 |